Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
An Open-label Phase I Study of GDC-0927 in Postmenopausal Women with Locally Advanced or Metastatic Estrogen Receptor-Positive Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 09, 2023
The exocyst complex and intracellular vesicles mediate soluble protein trafficking to the primary cilium.
Journal: Communications biology
Published: March 17, 2022
An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancer.
Journal: Gynecologic oncology
Published: August 10, 2021
Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199.
Journal: Molecular cancer therapeutics
Published: December 31, 2020
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Journal: Gynecologic oncology
Published: April 01, 2020
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 05, 2018
Anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) compared with pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer in a randomized, open-label, phase II study.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: February 06, 2018
High-Throughput and Sensitive Quantification of Circulating Tumor DNA by Microfluidic-Based Multiplex PCR and Next-Generation Sequencing.
Journal: The Journal of molecular diagnostics : JMD
Published: April 09, 2017
Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 05, 2016
Gli protein activity is controlled by multisite phosphorylation in vertebrate Hedgehog signaling.
Journal: Cell reports
Published: September 30, 2013
Last Updated: 09/26/2026